The fourth hurdle as controlling instrument for expenditure on medication?
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 1, p. 1, doi. 10.1007/s10198-003-0166-5
- By:
- Publication type:
- Article
Works matching IS 16187598 AND DT 2003 AND VI 4 AND IP 1
Results: 9
1
2
Cost-utility of interferon β<sub>1b</sub> in the treatment of patients with active relapsing-remitting or secondary progressive multiple sclerosis.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 1, p. 50, doi. 10.1007/s10198-002-0163-0
- By:
- Publication type:
- Article
3
The income elasticity of health care spending : A comparison of parametric and nonparametric approaches.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 1, p. 20, doi. 10.1007/s10198-002-0141-6
- By:
- Publication type:
- Article
4
The assessment of the economic return from controlled clinical trials : A framework applied to clinical trials of colorectal cancer follow-up.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 1, p. 6, doi. 10.1007/s10198-002-0142-5
- By:
- Publication type:
- Article
5
What criteria for pharmaceuticals reimbursement? : An empirical analysis of the evaluation of “medical service rendered” by reimbursable drugs in France.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 1, p. 30, doi. 10.1007/s10198-002-0145-2
- By:
- Publication type:
- Article
6
A pharmacoeconomic evaluation of escitalopram, a new selective serotonin reuptake inhibitor : Comparison of cost-effectiveness between escitalopram, citalopram, fluoxetine,and venlafaxine for the treatment of depression in Norway.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 1, p. 12
- By:
- Publication type:
- Article
7
Implementing standardized cost categories within economic evaluations in musculoskeletal diseases.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 1, p. 43, doi. 10.1007/s10198-002-0149-y
- By:
- Publication type:
- Article
8
The cost-effectiveness of early cabergoline treatment compared to levodopa in Sweden.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 1, p. 37, doi. 10.1007/s10198-002-0144-3
- By:
- Publication type:
- Article
9
Pricing and reimbursement of drugs in Denmark.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 1, p. 60, doi. 10.1007/s10198-003-0165-6
- By:
- Publication type:
- Article